WASHINGTON, DC: U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla in the Oval Office of the White House as he announces a deal with Pfizer to lower drug prices on September 30, ...

LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with Donald Trump's administration to ...

The Graft Versus Host Disease (GvHD) market across the seven major markets (7MM) is anticipated to witness substantial ...

The press conference that President Donald Trump hosted in the Oval Office with the CEO of drugmaker AstraZeneca on Friday played like a rerun of the late September Oval Office press conference with ...

AstraZeneca PLC announced a deal with President Donald Trump that’s focused on lowering drug prices, in a move that would see the British drugmaker follow in the footsteps of Pfizer Inc. “Today, ...

Nov 9 (Reuters) - An AstraZeneca (AZN.L), opens new tab executive said he felt encouraged by "incredibly promising" COVID-19 vaccine trial data unveiled by Pfizer and its German partner BioNTech, ...

After months of coercion, President Donald Trump has found another pharma giant willing to play ball with his "most favored nation" (MFN) drug pricing program. AstraZeneca has reached an agreement to ...

The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...

LONDON, Oct 10 (Reuters) - Wall Street is looking to U.S. drugmaker Eli Lilly (LLY.N), opens new tab and Anglo-Swedish rival AstraZeneca (AZN.L), opens new tab as the potential next in line after ...